Results 51 to 60 of about 42,664 (203)

Rubella virus genotype 2B endemicity and related utility of serum-based molecular characterization in Uganda

BMC Research Notes, 2023
There are 13 globally recognized rubella virus genotypes of which only 2 (1E and 2B) have been detected recently. The largest percentage of all reported rubella virus sequences come from China and Japan with Africa reporting limited data.
Phionah Tushabe, Barnabas Bakamutumaho, James Peter Eliku, Molly Birungi, Francis Aine, Prossy Namuwulya, Henry Bukenya, Immaculate Ampeire, Annet Kisakye, Charles R. Byabamazima, Josephine Bwogi   +10 more
doaj   +1 more source

Modelling Impact of Different Varicella Immunisation Strategies Upon Introduction in the Swedish National Programme

Acta Paediatrica, EarlyView.
ABSTRACT Aim Countries with varicella immunisation programmes have seen major reductions in disease burden. While two‐dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch‐up vaccination of older children to speed impact. This modelling study assessed three two‐dose schedules in the Swedish setting (1)
Gianpaolo Scalia Tomba, Frida Kasteng, Annika Ersson, Sören Andersson, Emma Appelqvist, Marie Nordahl, Kari Johansen   +6 more
wiley   +1 more source

Rubella polyneuropathy [PDF]

Postgraduate Medical Journal, 1975
Summary Two cases of polyneuropathy occurring after rubella infections are described, together with the nerve biopsy and serological findings.
openaire   +2 more sources

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

Acta Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson, Kari Johansen, Sören Andersson   +2 more
wiley   +1 more source

Health Economic Evaluation of Varicella Vaccination Within the Swedish National Vaccination Programme for Children

Acta Paediatrica, EarlyView.
ABSTRACT Aim To assess the cost‐effectiveness of including varicella vaccination in the Swedish national vaccination programme for children together with the added impact of catch‐up vaccination of susceptible older children. Methods An epidemiological transmission model was used to assess the cost‐effectiveness of a two‐dose national varicella ...
Frida Kasteng, Gianpaolo Scalia Tomba, Annika Ersson, Ellen Wolff, Sören Andersson, Kari Johansen   +5 more
wiley   +1 more source

Rubella epidemiology in Lesotho after vaccine introduction: a five-year review, 2018–2022

BMC Public Health
Background The rubella virus is a major contributor to birth defects globally and is preventable by vaccination. In 2020, the world was supposed to be free of both rubella and Congenital Rubella Syndrome (CRS) however this goal has yet to be realized ...
Thabelo Makhupane, DSK Habedi
doaj   +1 more source

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

Acta Paediatrica, EarlyView.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz, Raz Somech, Dan Dominissini, Nathan Keller, Efrat Dresner, Michal Paret, Gilad Sherman, Guy Katzenellenbogen, Elina Gelman, Keren Asraf, Ram Doolman, Atar Lev, Amos J. Simon, Helly Vernitsky, Assaf Barg, Hana Golan, Amos Toren, Michal Stein   +17 more
wiley   +1 more source

Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania

Italian Journal of Pediatrics, 2017
Background Childhood rubella infection is a mild, self-limiting illness. Rubella infection among pregnant women however, is a major public health concern.
Nikolas A. S. Chotta, Melina Mgongo, Jacqueline G. Uriyo, Sia E. Msuya, Babill Stray-Pedersen, Arne Stray-Pedersen   +5 more
doaj   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

Acta Paediatrica, EarlyView.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Rubella immune status of neonates – a window towards seroprevalence among childbearing women

BMC Public Health, 2016
Background When contracted in pregnancy, rubella may cause serious chronic infection of the fetus and development of Congenital Rubella Syndrome. Despite widespread application of rubella vaccination, periodical outbreaks are still being reported ...
Iris Pejcic, Milica Rankovic Janevski, Aleksandra Knezevic, Djordje Jevtovic, Maja Stanojevic   +4 more
doaj   +1 more source